In the context of IBD, however, the pro-inflammatory effects of IFN-I contribute to sustained, dysregulated expression of pro-inflammatory cytokines such as TNF, IL-1β, and IL-6. The gene discussed is TNF; the disease is inflammatory bowel disease.